Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rebecca A Clark & Kathleen E Squires. (2005) Gender-specific considerations in the antiretroviral management of HIV-infected women. Expert Review of Anti-infective Therapy 3:2, pages 213-227.
Read now
Read now
Articles from other publishers (8)
Nisha Andany & Mona R. Loutfy. (2013) HIV Protease Inhibitors in Pregnancy. Drugs 73:3, pages 229-247.
Crossref
Crossref
Maria Martinez-Rebollar, Montserrat Lonca, Iñaki Perez, Dolors Soy, Mercè Brunet, Rosa Martin, Oriol Coll, Sandra Hernandez, Montserrat Laguno, Ana Milinkovic, Maria Larrousse, Marta Calvo, Jose L Blanco, Esteban Martínez, Jose M Gatell & Josep Mallolas. (2011) Pharmacokinetic Study of Saquinavir 500 mg Plus Ritonavir (1000/100 mg Twice a Day) in HIV-Positive Pregnant Women. Therapeutic Drug Monitoring 33:6, pages 772-777.
Crossref
Crossref
Nils von Hentig, Gabi Nisius, Tessa Lennemann, Pavel Khaykin, Christoph Stephan, Errol Babacan, Schlomo Staszewski, Michael Kurowski, Sebastian Harder & Annette Haberl. (2008) Pharmacokinetics, Safety and Efficacy of Saquinavir/ Ritonavir 1,000/100 Mg Twice Daily as HIV Type-1 Therapy and Transmission Prophylaxis in Pregnancy. Antiviral Therapy 13:8, pages 1039-1046.
Crossref
Crossref
Carmen D. Zorrilla, Russell Van Dyke, Arlene Bardeguez, Edward P. Acosta, Betsy Smith, Michael D. Hughes, Sharon Huang, D. Heather Watts, Barbara Heckman, Eleanor Jiménez, George McSherry & Lynne Mofenson. (2007) Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants. Antimicrobial Agents and Chemotherapy 51:6, pages 2208-2210.
Crossref
Crossref
Luis F Lopez-Cortes, Rosa Ruiz-Valderas, Antonio Rivero, Angela Camacho, Manuel Marquez-Solero, Jesus Santos, Milagros García-Lazaro, Pompeyo Viciana, Jesus Rodriguez-Baños & Antonio Ocampo. (2007) Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy. Therapeutic Drug Monitoring 29:2, pages 171-176.
Crossref
Crossref
Esteban Ribera, Carlos Azuaje, Rosa M Lopez, Pere Domingo, Alex Soriano, Leonor Pou, Paquita Sánchez, Josep Mallolas, Maria Antonia Sambea, Vicenç Falco, Imma Ocaña, Josep Lluis Lopez-Colomes, Josep M Gatell & Albert Pahissa. (2005) Once-Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV-Infected Patients With Standard Tuberculosis Therapy (TBQD Study). JAIDS Journal of Acquired Immune Deficiency Syndromes 40:3, pages 317-323.
Crossref
Crossref
Rebecca Clark. (2005) Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events. Drug Safety 28:12, pages 1075-1083.
Crossref
Crossref
Hélène Chappuy, Jean-Marc Tréluyer, Elisabeth Rey, Jérôme Dimet, Maria Fouché, RN, Ghislaine Firtion, Gérard Pons & Laurent Mandelbrot. (2004) Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus. American Journal of Obstetrics and Gynecology 191:2, pages 558-562.
Crossref
Crossref